Eris Lifesciences share price
You have to be logged in to add this to Watchlist.Eris Lifesciences is trading 6.63% upper at Rs 1,467.45 as compared to its last closing price. Eris Lifesciences has been trading in the price range of 1,488.10 & 1,388.00. Eris Lifesciences has given 51.01% in this year & 3.39% in the last 5 days.
Eris Lifesciences has TTM P/E ratio 52.04 as compared to the sector P/E of 33.29.There are 8 analysts who have initiated coverage on Eris Lifesciences. There are 4 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 91.59 Crores in its last quarter.
Listed peers of Eris Lifesciences include Alembic Pharmaceuticals (5.29%), Wockhardt (5.00%), Eris Lifesciences (6.63%) etc.
Eris Lifesciences has a 45.13% public holding.The Mutual Fund holding in Eris Lifesciences was at 17.03% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Eris Lifesciences was at 8.01% in 30 Sep 2024. The FII holding has increased from the last quarter.
Eris Lifesciences share price range
|
| ||||
|
| ||||
Eris Lifesciences share Key Metrics
| Market Cap ( ₹ Cr.) | 18,703.66 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Eris Lifesciences Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 25-Oct-24 | Quarterly Results |
| 02-Aug-24 | Quarterly Results |
| 21-May-24 | Audited Results & Fund Raising |
| 13-Feb-24 | Quarterly Results |
| 08-Nov-23 | Quarterly Results |
| 07-Aug-23 | Quarterly Results |
| 17-May-23 | Audited Results |
| 17-Jan-23 | Quarterly Results |
| 20-Oct-22 | Quarterly Results |
| 05-Aug-22 | Quarterly Results & Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 25-Sep-24 | 04-Sep-24 | AGM |
| 25-Sep-23 | 08-Sep-23 | AGM |
| 01-Sep-21 | 29-Jul-21 | AGM |
| 26-Jul-21 | 22-Jun-21 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 02-Aug-22 | 16-Aug-22 | 11-Aug-22 | 7.35 |
| 26-Jul-21 | 06-Aug-21 | 05-Aug-21 | 6.01 |
FAQs about Eris Lifesciences share price
Eris Lifesciences is trading at 1467.45 as on Mon Nov 25 2024 10:13:15. This is 6.63% upper as compared to its previous closing price of 1376.15.
The market capitalization of Eris Lifesciences is 18703.66 Cr as on Mon Nov 25 2024 10:13:15.
The average broker rating on Eris Lifesciences is Strong Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Eris Lifesciences is 1521.05 whereas the 52 wk low is 810.10
Eris Lifesciences can be analyzed on the following key metrics -
- TTM P/E: 52.04
- Sector P/E: 33.29
- Dividend Yield: 0.00%
- D/E ratio: 0.99
Eris Lifesciences reported a net profit of 391.98 Cr in 2024.
Eris Lifesciences Quick Links
Eris Lifesciences Dividend Eris Lifesciences Bonus Eris Lifesciences News Eris Lifesciences AGM Eris Lifesciences Rights Eris Lifesciences Splits Eris Lifesciences Board Meetings Eris Lifesciences Key Metrics Eris Lifesciences Shareholdings Eris Lifesciences Profit Loss Eris Lifesciences Balance Sheet Eris Lifesciences Cashflow Eris Lifesciences Q1 Results Eris Lifesciences Q2 Results Eris Lifesciences Q3 Results Eris Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks